Stay updated on Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Minor metadata update: Revision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T16:23:30.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-23T14:54:25.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Notice about government funding and potential updates due to appropriations has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-16T14:30:53.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the study details page appears unchanged.
    Difference
    0.4%
    Check dated 2025-11-02T00:52:13.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Upgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.
    Difference
    4%
    Check dated 2025-10-04T12:11:46.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Updated version to v3.1.0 and removed the Head and neck squamous cell carcinoma resource from the Genetic and Rare Diseases Information Center. Overall impact is minor.
    Difference
    0.7%
    Check dated 2025-09-27T07:58:18.000Z thumbnail image

Stay in the know with updates to Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib Plus Nivolumab Combo in Solid Tumors Clinical Trial page.